Detalles de la búsqueda
1.
Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared With Warfarin or Non-Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation.
Stroke
; 49(6): 1464-1470, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29739915
2.
Variation in Health Technology Assessment and Reimbursement Processes in Europe.
Value Health
; 20(1): 67-76, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28212972
3.
A Framework for Developing the Structure of Public Health Economic Models.
Value Health
; 19(5): 588-601, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27565276
4.
Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin.
Europace
; 18(7): 979-86, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26838691
5.
Cost-effectiveness of left atrial appendage closure with Watchman for non-valvular atrial fibrillation patients in Japan.
J Med Econ
; 26(1): 1357-1367, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37819734
6.
Cost-Effectiveness of Left Atrial Appendage Closure for Stroke Reduction in Atrial Fibrillation: Analysis of Pooled, 5-Year, Long-Term Data.
J Am Heart Assoc
; 8(13): e011577, 2019 07 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31230500
7.
A systematic literature review of the key challenges for developing the structure of public health economic models.
Int J Public Health
; 61(3): 289-98, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26747470
8.
Time to Cost-Effectiveness Following Stroke Reduction Strategies in AF: Warfarin Versus NOACs Versus LAA Closure.
J Am Coll Cardiol
; 66(24): 2728-2739, 2015 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-26616031
9.
Economic implications of the use of basiliximab in addition to triple immunosuppressive therapy in renal allograft recipients: a UK perspective.
Pharmacoeconomics
; 21(2): 129-38, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-12515574
10.
A cost-effectiveness analysis of celecoxib compared with diclofenac in the treatment of pain in osteoarthritis (OA) within the Swedish health system using an adaptation of the NICE OA model.
J Med Econ
; 17(9): 677-84, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24914585
11.
Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension.
J Am Coll Cardiol
; 60(14): 1271-7, 2012 Oct 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-22981547
12.
A qualitative study of manufacturers' submissions to the UK NICE single technology appraisal process.
BMJ Open
; 2: e000562, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22318664
13.
Reply: Considerations When Evaluating Cost-Effectiveness Analyses of Novel Stroke Prevention Therapies.
J Am Coll Cardiol
; 67(18): 2194-2195, 2016 05 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27151357
14.
The economics of basiliximab (Simulect) in preventing acute rejection in renal transplantation.
Transpl Int
; 15(9-10): 486-93, 2002 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-12389081
Resultados
1 -
14
de 14
1
Próxima >
>>